BSF Enterprise Plc (BSFA) - Total Assets
Based on the latest financial reports, BSF Enterprise Plc (BSFA) holds total assets worth GBX3.01 Million GBX (≈ $365.85 USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See debt-free asset ratio of BSF Enterprise Plc to measure how much of total assets are equity-financed.
BSF Enterprise Plc - Total Assets Trend (2019–2025)
This chart illustrates how BSF Enterprise Plc's total assets have evolved over time, based on quarterly financial data. Check BSF Enterprise Plc (BSFA) tangible equity ratio to evaluate the tangible quality of the company's equity base.
BSF Enterprise Plc - Asset Composition Analysis
Current Asset Composition (September 2025)
BSF Enterprise Plc's total assets of GBX3.01 Million consist of 15.6% current assets and 84.4% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 5.0% |
| Accounts Receivable | GBX230.09K | 7.7% |
| Inventory | GBX87.14K | 2.9% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX2.49 Million | 82.7% |
Asset Composition Trend (2019–2025)
This chart illustrates how BSF Enterprise Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BSF Enterprise Plc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BSF Enterprise Plc's current assets represent 15.6% of total assets in 2025, a decrease from 100.0% in 2019.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 100.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 82.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 82.7% of total assets.
BSF Enterprise Plc Competitors by Total Assets
Key competitors of BSF Enterprise Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $8.59 Billion |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
USA | $763.95 Million |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
|
China | CN¥4.48 Billion |
|
Novavax Inc
NASDAQ:NVAX
|
USA | $1.04 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF2.64 Billion |
BSF Enterprise Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 2.96 | 14.12 |
| Quick Ratio | 1.38 | 2.74 | 14.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX192.40K | GBX567.40K | GBX423.14K |
BSF Enterprise Plc - Advanced Valuation Insights
This section examines the relationship between BSF Enterprise Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.85 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -14.0% |
| Total Assets | GBX3.01 Million |
| Market Capitalization | $15.23K USD |
Valuation Analysis
Below Book Valuation: The market values BSF Enterprise Plc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BSF Enterprise Plc's assets decreased by 14.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BSF Enterprise Plc (2019–2025)
The table below shows the annual total assets of BSF Enterprise Plc from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | GBX3.01 Million ≈ $365.85 |
-13.98% |
| 2024-09-30 | GBX3.50 Million ≈ $425.30 |
-33.55% |
| 2023-09-30 | GBX5.26 Million ≈ $640.06 |
+30.46% |
| 2022-09-30 | GBX4.03 Million ≈ $490.63 |
+904.48% |
| 2021-09-30 | GBX401.45K ≈ $48.84 |
-11.85% |
| 2020-09-30 | GBX455.40K ≈ $55.41 |
-17.53% |
| 2019-09-30 | GBX552.20K ≈ $67.19 |
-- |
About BSF Enterprise Plc
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom.